Transfusion alert for patients with curable cancer

World Journal of Surgery

Volumn 31, Issue 12, 2007, Pages 2315-2322

  Yamashita, Keishi ^a   Sakuramoto, Shinichi ^a   Kikuchi, Shiroh ^a   Katada, Natsuya ^a   Kobayashi, Nobuyuki ^a   Watanabe, Masahiko ^a  

^a KITASATO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD TRANSFUSION; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTOR VARIABLE; PROGNOSIS; SPLENECTOMY; STOMACH CANCER; STRATIFICATION;

ADENOCARCINOMA; BLOOD TRANSFUSION; FEMALE; GASTRECTOMY; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERIOPERATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDIES; SPLENECTOMY; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 36849029769     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-007-9237-6     Document Type: Article

References (26)

1. Busch OR, Hop WC, Hoynck van Papendrecht MA, et al. (1993) Blood transfusions and prognosis in colorectal cancer. N Engl J Med 328(19):1372-1376
2. Houbiers JG, Brand A, van de Watering LM, et al. (1994) Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet 344(8922):573-578
3. Lapierre V, Auperin A, Tiberghien P (1998) Transfusion-induced immunomodulation following cancer surgery: fact or fiction? J Natl Cancer Inst 90(8):573-580
4. Jensen LS, Puho E, Pedersen L, et al. (2005) Long-term survival after colorectal surgery associated with buffy-coat-poor and leucocyte-depleted blood transfusion: a follow-up study. Lancet 365(9460):681-682
5. Rosenberg SA, Seipp CA, White DE, et al. (1985) Perioperative blood transfusions are associated with increased rates of recurrence and decreased survival in patients with high-grade soft-tissue sarcomas of the extremities. J Clin Oncol 3(5):698-709
6. Fong Y, Karpeh M, Mayer K, et al. (1994) Association of perioperative transfusion with poor outcome in resection of gastric adenocarcinoma. Am J Surg 167:256-260
7. Maeta M, Shimizu N, Oka A, et al. (1994) Perioperative allogeneic blood transfusion exacerbates surgical stress-induced postoperative immunosuppression and has a negative effect on prognosis in petients with gastric cancer. J Surg Oncol 55:149-153
8. Hyung WJ, Noh SH, Shin DW, et al. (2002) Adverse effects of perioperative transfusion on patients with stage III and IV gastric cancer. Ann Surg Oncol 9(1):5-12
9. Weitz J, D'Angelica M, Gonen M, et al. (2003) Interaction of splenectomy and perioperative blood transfusions on prognosis of patients with proximal gastric and gastroesophageal junction cancer. J Clin Oncol 21(24):4597-4603
10. Nio Y, Tsubono M, Kawabata K, et al. (1993) Comparison of survival curves of gastric cancer patients after surgery according to the UICC stage classification and the General Rules for Gastric Cancer Study by the Japanese Research Society for gastric cancer. Ann Surg 218(1):47-53
11. Ikeguchi M, Murakami D, Kanaji S, et al. (2004) Lymph node metastasis of gastric cancer: comparison of Union International Contra Cancer and Japanese systems. ANZ J Surg 74(10):852-854
12. Nio Y, Yamasawa K, Yamaguchi K, et al. (2003) Problems in the N-classification of the new 1997 UICC TNM stage classification for gastric cancer: an analysis over 10 years' outcome of Japanese patients. Anticancer Res 23(1B):697-705
13. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481
14. Cox DR (1972) Regression models and life-tables. J R Stat Soc (B) 34:187-220
15. Al-Mehdi AB, Tozawa K, Fisher AB, et al. (2000) Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat Med 6(1):100-102
16. Bohlius J, Langensiepen S, Schwarzer G, et al. (2005) Recombinant human erythropoietin and overall survival in cancer patients: results of a comprehensive meta-analysis. J Natl Cancer Inst 97(7):489-498
17. Miller CB, Platanias LC, Mills SR, et al. (1992) Phase I-II trial of erythropoietin in the treatment of cisplatin-associated anemia. J Natl Cancer Inst 98-103
18. Case DC Jr, Bukowski RM, Carey RW, et al. (1993) Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy. J Natl Cancer Inst 85(10):801-806
19. Seidenfeld J, Piper M, Flamm C, et al. (2001) Epoetin treatment of anemia associated with cancer therapy: a systemic review and meta-analysis of controlled clinical trials. J Natl Cancer Inst 93(16):1204-1214
20. Vansteenkiste J, Pirker R, Massuti B, et al. (2002) Double-blind, placebo-controlled, randamized phase III trial of darbepoietin alfa in lung cancer patients receiving chemotherapy. J Natl Cancer Inst 94(16):1211-1220
21. Cella D, Zagari MJ, Vandoros C, et al. (2003) Epoetin alfa treatment results in clinically significant improvements in quality of life in anemic cancer patients when referenced to the general population. J Clin Oncol 21(2):366-373
22. Witzig TE, Silberstein PT, Loprinzi CL, et al. (2005) Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy. J Clin Oncol 23(12):2606-2617
23. Chang J, Couture F, Young S, et al. (2005) Weekly epoietin alfa maintains hemoglobin, improves quality of life, and reduces transfusion in breast cancer patients receiving chemotherapy. J Clin Oncol 23(12):2597-2605
24. Steensma DP, Molina R, Sloan JA, et al. (2006) Phase III study of two different dosing schedules of erythropoietin in anemic patients with cancer. J Clin Oncol 24(7):1079-1089
25. Glaspy J, Vadhan-Raj S, Patel R, et al. (2006) Randamized comparison of every-2-week darbepoietin alfa and weekly epoietin alfa for the treatment of chemotherapy-induced anemia: the 20030125 Study Group Trial. J Clin Oncol 24(15):2290-2297
26. Bohlius J, Wilson J, Seidenfeld J, et al. (2006) Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients. J Natl Cancer Inst 98(10):708-714